Clinical trial
Randomized Phase II Trial of Two Different Nutritional Approaches for Patients Receiving Treatment for Their Advanced Pancreatic Cancer
NCT04631445 is registered in ClinicalTrials.gov with Translational Drug Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Trial of Two Different Nutritional Approaches for Patients Receiving Treatment for Their Advanced Pancreatic Cancer
- Lead sponsor
- Translational Drug Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 2, 2020
- Completion date
- February 1, 2025
- Enrollment
- 32 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic pancreatic ductal adenocarcinoma